Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals-Reference-Cited by-同舟云学术

Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals

Published:2007-10 Issue:10 Volume:9 Page:652-662
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Muñoz-Casares F. C.,Rufián S.,Rubio M. J.,Lizárraga E.,Díaz-Iglesias C.,Aranda E.,Ciria R.,Muntané J.,Barrios P.,Torres-Melero J.,González-Moreno S.,González-Bayón L.,Camps B.,Bretcha P.,Farré J.,Ortega-Pérez G.,Gómez-Portilla A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-007-0118-0.pdf

Reference83 articles.

1. Jemal A, Siegel RT, Ward E et al (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66

2. Poveda A (2003) Ovarian cancer treatment: what is new. Int J Gynecol Cancer 13:241–250

3. Sugarbaker PH (1998) Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 14:254–261

4. Jahne J, Piso P (1998) Peritonectomy and intraperitoneal chemotherapy — new methods in multi-modality therapy of peritoneal carcinosis. Langenbecks Arch Chir Suppl Kongressbd 115:1435–1437

5. Coakley FV (2002) Staging ovarian cancer: role of imaging. Radiol Clin North Am 40:609–636

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cirugía citorreductora radical y quimioterapia intraperitoneal hipertérmica en el tratamiento de la sarcomatosis peritoneal: resultados de un centro referente y reflexiones sobre la evidencia actual;Cirugía Española;2024-08

2. Radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal sarcomatosis: Results from a reference center and considerations based on current evidence;Cirugía Española (English Edition);2024-08

3. Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer;Frontiers in Oncology;2022-12-21

4. RETRACTED ARTICLE: Upfront citorreduction and hyperthermic intraperitoneal chemotherapy with paclitaxel in patients with stage III-C serous epithelial ovarian cancer;Clinical & Experimental Metastasis;2019-12-06

5. Ascites do not affect the rate of complete cytoreductive surgery and prognosis in patients with primary ovarian cancer with ascites treated with hyperthermic intraperitoneal chemotherapy;Oncology Letters;2019-06-19